Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07867171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Effects of Moderate or Severe Renal Impairment (RI) on Velzatinib

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GlaxoSmithKline
246 trials monitored
See 20 trials at risk
This study evaluates the effect of moderate and severe renal impairment on the pharmacokinetics (PK) of velzatinib compared with normal renal function.
Trial Details
NCT Number NCT07867171
Lead Sponsor GlaxoSmithKline
Conditions
(from sponsor)		 Healthy Participants, Gastrointestinal Neoplasms
Related terms Gastrointestinal Neoplasms, Renal Insufficiency
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov